RhumbLine Advisers’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $330K | Sell |
96,422
-3,065
| -3% | -$9.53K | ﹤0.01% | 3010 |
|
|
2026
Q1 | $227K | Buy |
+99,487
| New | +$229K | ﹤0.01% | 3060 |
|
|
2025
Q4 | – | Sell |
-122,061
| Closed | -$586K | – | 4162 |
|
|
2025
Q3 | $586K | Sell |
122,061
-107,568
| -47% | -$684K | ﹤0.01% | 2583 |
|
|
2025
Q2 | $2.09M | Buy |
229,629
+6,309
| +3% | +$46.5K | ﹤0.01% | 1862 |
|
|
2025
Q1 | $2.02M | Sell |
223,320
-9,652
| -4% | -$102K | ﹤0.01% | 1804 |
|
|
2024
Q4 | $3.04M | Sell |
232,972
-774
| -0.3% | -$10.3K | ﹤0.01% | 1667 |
|
|
2024
Q3 | $3.67M | Sell |
233,746
-3,325
| -1% | -$50.4K | ﹤0.01% | 1586 |
|
|
2024
Q2 | $3.2M | Sell |
237,071
-7,002
| -3% | -$143K | ﹤0.01% | 1636 |
|
|
2024
Q1 | $6.76M | Sell |
244,073
-1,424
| -0.6% | -$31.6K | 0.01% | 1255 |
|
|
2023
Q4 | $4.73M | Sell |
245,497
-2,349
| -0.9% | -$42.5K | 0.01% | 1456 |
|
|
2023
Q3 | $4.01M | Buy |
247,846
+660
| +0.3% | +$11.7K | ﹤0.01% | 1481 |
|
|
2023
Q2 | $4.71M | Sell |
247,186
-1,347
| -0.5% | -$24K | 0.01% | 1414 |
|
|
2023
Q1 | $3.62M | Buy |
248,533
+10,031
| +4% | +$180K | ﹤0.01% | 1498 |
|
|
2022
Q4 | $4.66M | Buy |
238,502
+4,328
| +2% | +$84.4K | 0.01% | 1317 |
|
|
2022
Q3 | $5.64M | Buy |
234,174
+8,454
| +4% | +$261K | 0.01% | 1156 |
|
|
2022
Q2 | $7.1M | Buy |
225,720
+27,401
| +14% | +$993K | 0.01% | 1077 |
|
|
2022
Q1 | $8.73M | Buy |
198,319
+9,572
| +5% | +$411K | 0.01% | 1013 |
|
|
2021
Q4 | $8.21M | Buy |
188,747
+5,108
| +3% | +$200K | 0.01% | 1093 |
|
|
2021
Q3 | $5.75M | Sell |
183,639
-28,736
| -14% | -$1.13M | 0.01% | 1274 |
|
|
2021
Q2 | $8.99M | Sell |
212,375
-32,444
| -13% | -$1.26M | 0.01% | 1074 |
|
|
2021
Q1 | $9.2M | Buy |
244,819
+4,861
| +2% | +$152K | 0.01% | 1049 |
|
|
2020
Q4 | $6.49M | Buy |
239,958
+41,041
| +21% | +$1.06M | 0.01% | 1203 |
|
|
2020
Q3 | $5M | Sell |
198,917
-17,466
| -8% | -$255K | 0.01% | 1168 |
|
|
2020
Q2 | $1.65M | Sell |
216,383
-9,113
| -4% | -$66.7K | ﹤0.01% | 1837 |
|
|
2020
Q1 | $2.06M | Buy |
225,496
+14,063
| +7% | +$84.9K | ﹤0.01% | 1526 |
|
|
2019
Q4 | $1.09M | Buy |
211,433
+10,299
| +5% | +$66.1K | ﹤0.01% | 2037 |
|
|
2019
Q3 | $1.17M | Buy |
201,134
+10,384
| +5% | +$46.6K | ﹤0.01% | 1963 |
|
|
2019
Q2 | $610K | Buy |
190,750
+7,699
| +4% | +$26.3K | ﹤0.01% | 2274 |
|
|
2019
Q1 | $751K | Sell |
183,051
-73,173
| -29% | -$463K | ﹤0.01% | 2155 |
|
|
2018
Q4 | $1.62M | Buy |
256,224
+31,061
| +14% | +$322K | ﹤0.01% | 1774 |
|
|
2018
Q3 | $3.72M | Buy |
225,163
+31,908
| +17% | +$542K | 0.01% | 1310 |
|
|
2018
Q2 | $3.23M | Buy |
193,255
+40
| +0% | +$648 | 0.01% | 1390 |
|
|
2018
Q1 | $3M | Buy |
193,215
+39,900
| +26% | +$711K | 0.01% | 1365 |
|
|
2017
Q4 | $2.9M | Sell |
153,315
-17,739
| -10% | -$393K | 0.01% | 1407 |
|
|
2017
Q3 | $5M | Buy |
171,054
+10,002
| +6% | +$295K | 0.01% | 1036 |
|
|
2017
Q2 | $5.18M | Sell |
161,052
-5,192
| -3% | -$170K | 0.01% | 980 |
|
|
2017
Q1 | $5.75M | Sell |
166,244
-6,700
| -4% | -$239K | 0.01% | 923 |
|
|
2016
Q4 | $6.1M | Sell |
172,944
-2,856
| -2% | -$96.5K | 0.02% | 838 |
|
|
2016
Q3 | $6.11M | Buy |
175,800
+9,450
| +6% | +$331K | 0.02% | 780 |
|
|
2016
Q2 | $6.22M | Sell |
166,350
-21,122
| -11% | -$794K | 0.02% | 738 |
|
|
2016
Q1 | $7.58M | Buy |
187,472
+11,270
| +6% | +$420K | 0.02% | 645 |
|
|
2015
Q4 | $6.34M | Buy |
176,202
+620
| +0.4% | +$22.4K | 0.02% | 706 |
|
|
2015
Q3 | $5.61M | Buy |
175,582
+6,635
| +4% | +$226K | 0.02% | 753 |
|
|
2015
Q2 | $5.74M | Buy |
168,947
+200
| +0.1% | +$6.74K | 0.02% | 767 |
|
|
2015
Q1 | $5.71M | Sell |
168,747
-4,200
| -2% | -$146K | 0.02% | 770 |
|
|
2014
Q4 | $6.07M | Sell |
172,947
-4,247
| -2% | -$143K | 0.02% | 699 |
|
|
2014
Q3 | $5.8M | Sell |
177,194
-47,010
| -21% | -$1.6M | 0.02% | 702 |
|
|
2014
Q2 | $7.62M | Sell |
224,204
-11,027
| -5% | -$378K | 0.02% | 593 |
|
|
2014
Q1 | $8.24M | Sell |
235,231
-2,670
| -1% | -$94.2K | 0.02% | 573 |
|
|
2013
Q4 | $8.7M | Sell |
237,901
-750
| -0.3% | -$27.5K | 0.03% | 547 |
|
|
2013
Q3 | $8.26M | Buy |
238,651
+51,229
| +27% | +$1.79M | 0.03% | 571 |
|
|
2013
Q2 | $6.34M | Buy |
+187,422
| New | +$6.22M | 0.02% | 667 |
|
Other funds holding ACH
CCM
ICM
PCMI
RhumbLine Advisers's ACH Position: Q2 2026 in Review
RhumbLine Advisers reduced its Accendra Health (ACH) stake by 3.1% in Q2 2026, selling an estimated $9.53K and leaving 96,422 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #3010.
RhumbLine Advisers first reported a position in ACH in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.2M in Q1 2021. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- RhumbLine Advisers held 96,422 shares of Accendra Health worth $330K as of Q2 2026.
- RhumbLine Advisers sold 3,065 Accendra Health shares in Q2 2026, an estimated $9.53K.
- Accendra Health made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3010 holding.
- RhumbLine Advisers first reported a position in Accendra Health in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's Accendra Health position peaked at $9.2M in Q1 2021.
- 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.